Table 2 Main demographic and clinical characteristics of migraine patients enrolled in the study
From: Tracking the evolution of non-headache symptoms through the migraine attack
Median age [IQ range] (years) | 46 [34–54] |
Women/Men | 174 (77%) - 51 (23%) |
Median disease duration [IQ range] (years) | 30 [18–39] |
Migraine with aura/Migraine without aura | 48 (21%) – 177 (79%) |
Median monthly headache days [IQ range] | 15 [8–26] |
Median monthly migraine days [IQ range] | 12 [8–18] |
Episodic/Chronic migraine | 100 (44%) – 125 (56%) |
Median of preventive treatments used in the past [IQ range] | 3 [0.5–5] |
Migraine with medication overuse/ Migraine without medication overuse | 112 (49%) – 113 (51%) |
Median of monthly tablets of acute treatments [IQ range] | 15 [8–26] |
Median MIDAS score [IQ range] | 36 [15–89] |
Median HIT-6 score [IQ range] | 65 [61–68] |
Median NRS score [IQ range] | 8 [7–8.5] |
Median ASC-12 score [IQ range] | 4 [1–7] |